期刊文献+

血浆(1,3)-β-D葡聚糖检测对器官移植患者侵袭性真菌感染诊断价值 被引量:8

The diagnostic value of plasma 1,3-β-D glucan to invasive fungal infection in organ transplant recipients
下载PDF
导出
摘要 目的探讨血浆(1,3)-β-D葡聚糖(BG)检测(G试验)在诊断器官移植术后合并侵袭性真菌感染(IFI)的诊断价值。方法回顾性分析2011年1月~2012年12月130例在本院肝、肾移植中心住院疑似IFI的患者的血浆标本,进行G实验检测。其中64例最终确诊或临床诊断为IFI患者,设为IFI组,余66例为非IFI组。应用MB-80微生物动态快速检测系统和GKT-5M Set动态真菌检测试剂盒,血浆BG浓度≥10 pg/mL判定G试验阳性。采用四格表计算G试验诊断IFI的敏感度、特异度、阳性预测值和阴性预测值。对G试验结果进行受试者特征工作曲线(ROC曲线)分析,并计算曲线下面积。结果 130例患者中,IFI组中G试验阳性57/64,阳性率89.1%;阴性7例,假阴性率10.9%。非IFI组G试验阳性15/66,假阳性率22.7%。G试验阳性诊断IFI的敏感度、特异度、阳性预值和阴性预测值分别为89.1%,77.3%,79.2%和87.9%。根据G试验结果绘制ROC曲线,曲线下面积为0.875(95%CI:0.813~0.937)。结论 G试验对器官移植患者IFI具有中等诊断价值。适当提高诊断界值及重复检测可较大程度地消除假阳性。 Objective To evaluate the diagnostic value of plasma 1,3-β-D glucan (BG) assay (G test) to invasive fungal infection (IFI) in organ transplant recipients. Methods By retrospectively accessing the clinical data of pediatric inpatients who underwent G test. The patients being recruited from January 2011 to December 2012 were split into two groups: group IFI comprised 64 pa- tients with proven and probable IFI. Group control comprised 66 patients without fungal infection. G test was performed by the GKT- 5 M Set Kinetic Fungus Detection Kit. It was judged as positive when the plasma BG level ≥ 10 pg/mL. 2 by 2 table was used to cal- culate the G test for the diagnosis of IFI sensitivity, specificity, positive predictive value and negative predictive values. Receiver operating curve (ROC) of G test was analyzed, and the area under the curve was calculated. Results In IFI group G test was positive in 57 cases, the positive rate was 89.06%. 15 cases of non-IFI group were positive, false positive rate was 22.7%. The G test sensitivity, specificity , positive and negative predictive values were89.1% ,77.3% ,79.2% and 87.9% respectively. According to ROC analysis, the AUC was 0. 875 (95 % CI : 0.813 - 0. 937). Conclusions G test has good diagnostic value of IFI in organ transplant patients . Appropriately higher cutoffs or continuous monitoring may significantly control false positive rate of the test.
出处 《中国真菌学杂志》 CSCD 2013年第3期151-155,共5页 Chinese Journal of Mycology
基金 国家重点基础研究发展计划(2013CB531603)
关键词 血浆(1 3)-β-D葡聚糖 器官移植 侵袭性真菌感染 诊断 ( 1-3 ) -β-D -glucan organ transplant patients invasive fungal infection diagnosis
  • 相关文献

参考文献15

  • 1Neofytos D, Fishman JA, Hom D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients[J]. Transpl Infect Dis ,2010,12(3) :220-229.
  • 2Brissaud 0, Guichoux J, Harambat J , et al. Invasive fungal disease in Picu : epidemiology and risk factors [J]. Ann Intensive Care,2012,22,2(l) :6.
  • 3Gonzalez JJ, Pintor E, Hinojosa J, et al. Invasive aspergillosis in patients with human immunodeficiency virus infection diagnosed by necropsy : the contribution of 4 cases and review of the literature[J]. Enferm Infecc Microbiol Clin,1999, 17(2) :69-73.
  • 4Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections [J]. Clin Microbiol Rev, 2002,15(3) :465484.
  • 5实体器官移植患者侵袭性真菌感染的诊断和治疗指南[J].中华器官移植杂志,2009,30(7):440-441. 被引量:14
  • 6Obayashi T, Negishi K, Suzuki T, et al. Reappraisal of the serum (1-3) -β-D-glucan assay for the diagnosis of invasive fungal infections-a study based on autopsy cases from 6 years [J]. Clin Infect Dis 2008,46(12) : 1864-1870.
  • 7Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1-3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans [J]. Clin Infect Dis ,2005,1 (5) :654-659.
  • 8Persat F, Ranque S, Derouin F, et al. Contribution of the (1- 3) -β-D-glucan assay for diagnosis of invasive fungal infections [J]. J Clin Microbiol ,2008,46 (3) : 1009-1013.
  • 9Albert O, Toubas D, Strady C, et al. Reactivity of (1-3) -β-dglucan assay in bacterial bloodstream infections [J]. Eur J Clin Microbiollnfect Dis,2011 ,30(11) : 1453-1460.
  • 10Hadley S, Samore MH, Lewis WD, et al. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression [J]. Transplantation 1995,59 (6): 851-859.

二级参考文献4

共引文献13

同被引文献63

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部